Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × enfortumab vedotin × Clear all

NCT05915351 2025-04-16

Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms